Clinical Trials on Pontocerebellar Hypoplasia Type 6 in Canada

Total 2 results

PTC Therapeutics

Completed

A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy (MIT-E)

Mitochondrial Diseases | Drug Resistant Epilepsy | Leigh Disease | Leigh Syndrome | Mitochondrial Encephalopathy (MELAS) | Pontocerebellar Hypoplasia Type 6 (PCH6) | Alpers Disease | Alpers Syndrome

United States, Spain, United Kingdom, Canada, France, Italy, Poland, Sweden, Japan
Nova Scotia Health Authority

Unknown

Genetic Identification (ID) of Segmental Dysplastic Nevi

Segmental Dysplastic Nevi

Canada

3

Subscribe